Provided is a novel immunity inducing agent that is useful as a cancer treatment and/or prevention agent or the like. The immunity inducing agent contains as an active ingredient: at least one polypeptide having immunity inducing activity and selected from polypeptides (a)(b) and (c) namely(a) a polypeptide comprising at least seven successive amino acids in the amino acid sequence indicated by sequence number 4, 2, 8, 10 or 12 in the sequence table(b) a polypeptide comprising at least seven amino acids and having a sequence identity of at least 85% with respect to polypeptide (a) and (c) a polypeptide containing polypeptide (a) or (b) as a partial sequence or a recombinant vector that can express the polypeptide in vivo and contains a polynucleotide that codes for the polypeptide.
